News

A single dose of a chromium-enriched glucomannan-fructo-oligosaccharide fiber complex significantly reduced postprandial ...
Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.
We have five products that will launch in the next 12-18 months. We recently launched Yesintek in the immunology space -- a ...
Introduction Globally, one in two people needing insulin lack access. High prices and poor availability are thought to be key contributors to poor insulin access. However, few studies have assessed ...
The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...
Find more information on the Altmetric Attention Score and how the score is calculated. Clinical trials of intranasal insulin treatment for Alzheimer’s patients have shown cognitive and memory ...
Explore our Reviews for real insights on this plant-based blood sugar supplement ingredients, and where to buy safely.
Novel alkylphospholipid analogues may provide safer and more effective alternatives. OBJECTIVES This study aimed to assess the antileishmanial activity, cytotoxicity, and membrane interactions of ...
hypothesizing that resistance developed against the previous insulin analogs. A titration upwards to 75 U of long-acting insulin and around 100–110 U of rapid-acting insulin was needed, without ...
Leading Indian drugmakers such as Eris Lifesciences, Lupin, Mankind and Wockhardt are making strong inroads into the country's insulin market-long dominated by multinationals such as Novo Nordisk, ...
Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4935, Department of Pharmacology and Biological Chemistry, Mt. Sinai School of Medicine of New ...
Demographic trends are strengthened by a market shift from human insulin toward modern insulin analogs (Novo's Levemir and NovoLog), next-generation insulin analogs (Tresiba, Fiasp), and a novel ...